Search for a command to run...
Introduction: Against the backdrop of an aging global population, cognitive decline poses significant challenges to individuals' quality of life. Currently, therapeutic interventions for cognitive impairment, particularly in neurological disorders such as Alzheimer's Disease (AD), remain limited. DHCR24 (3β-dehydrocholesterol-Δ24-reductase), a cholesterol synthase, has been shown to exert neuroprotective effects in AD by mitigating oxidative stress. This study aims to delineate the specific molecular mechanisms through which DHCR24 influences cognitive learning function. Methods: A total of twenty mice were randomly assigned to either an experimental group or a control group. DHCR24 expression was pharmacologically downregulated, and synaptic plasticity was examined using slice patch-clamp recordings. Additionally, Barnes-Maze testing was performed to evaluate the role of DHCR24 in learning and memory functions. The influence of DHCR24 on endogenous neural stem cell differentiation was further analyzed by fluorescence immunohistochemistry. Results: The findings of this study demonstrated that U18666A effectively suppressed DHCR24 expression. This downregulation was associated with the inhibition of endogenous neural stem cell differentiation and a reduction in the expression of the synaptic AMPA receptor subunit GluA2. Consistent with these molecular changes, patch-clamp recordings revealed a corresponding attenuation of AMPA receptor-mediated synaptic plasticity. Behavioral assessments further corroborated that pharmacological inhibition of DHCR24 resulted in significant cognitive impairment in mice. Discussion: This study implicates DHCR24 as a key factor capable of modulating cognitive function, thereby offering a novel direction and potential intervention target for research on Alzheimer's disease and neurodegeneration. Conclusion: DHCR24 represents a promising novel target for cognitive enhancement.